Metformin Hydrochloride Zentiva

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Zentiva, is a Biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients.

GNH USA supplies Metformin Hydrochloride Zentiva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is an oral antidiabetic medication used in the management of type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hypoglycemia: uncommon when used alone, may occur with other glucose‑lowering agents. - Pancreatitis: very rare inflammation of the pancreas.

Metformin Hydrochloride requires careful monitoring and patient education to minimize risks.

- Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic function: evaluate liver enzymes, especially in patients with known liver disease. - Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia or severe infection. - Elderly patients: start at lower doses and monitor tolerance closely. - Concomitant medications: review for drugs that may impair renal function or increase lactate production. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - MAO inhibitors: potential for severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - Corticosteroids: may increase blood glucose, requiring dose adjustment. - Alcohol: excessive intake raises lactic acidosis risk. - Thyroid hormones: may alter glucose metabolism.